Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pathogenesis of Nonalcoholic Steatohepatitis and Hormone-Based Therapeutic Approaches
Kook Hwan Kim, Myung‐Shik Lee
Frontiers in Endocrinology (2018) Vol. 9
Open Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

Acetyl-CoA carboxylase (ACC) as a therapeutic target for metabolic syndrome and recent developments in ACC1/2 inhibitors
Leyuan Chen, Yuqing Duan, Huiqiang Wei, et al.
Expert Opinion on Investigational Drugs (2019) Vol. 28, Iss. 10, pp. 917-930
Closed Access | Times Cited: 112
Direct AMPK Activation Corrects NASH in Rodents Through Metabolic Effects and Direct Action on Inflammation and Fibrogenesis
Pascale Gluais Dagorn, Marc Foretz, Gregory R. Steinberg, et al.
Hepatology Communications (2021) Vol. 6, Iss. 1, pp. 101-119
Open Access | Times Cited: 55
NFATc1 signaling drives chronic ER stress responses to promote NAFLD progression
Muhammad Umair Latif, G. Schmídt, Sercan Mercan, et al.
Gut (2022) Vol. 71, Iss. 12, pp. 2561-2573
Open Access | Times Cited: 40
The role of FGF21 and its analogs on liver associated diseases
Kimia Falamarzi, Mahdi Malekpour, Mobin Fallah Tafti, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 38
Berberine prevents NAFLD and HCC by modulating metabolic disorders
Xinyue Lin, Jilei Zhang, Yajun Chu, et al.
Pharmacology & Therapeutics (2024) Vol. 254, pp. 108593-108593
Closed Access | Times Cited: 11
Non-alcoholic fatty liver disease: An overview of risk factors, pathophysiological mechanisms, diagnostic procedures, and therapeutic interventions
Samar H. Gerges, Sara A. Wahdan, Doaa A. Elsherbiny, et al.
Life Sciences (2021) Vol. 271, pp. 119220-119220
Closed Access | Times Cited: 52
GDF15 as a central mediator for integrated stress response and a promising therapeutic molecule for metabolic disorders and NASH
Kook Hwan Kim, Myung‐Shik Lee
Biochimica et Biophysica Acta (BBA) - General Subjects (2020) Vol. 1865, Iss. 3, pp. 129834-129834
Closed Access | Times Cited: 51
Multifactorial Basis and Therapeutic Strategies in Metabolism-Related Diseases
João Victor da Silva Guerra, Marieli M. G. Dias, Anna Julyana Viana Chianca Brilhante, et al.
Nutrients (2021) Vol. 13, Iss. 8, pp. 2830-2830
Open Access | Times Cited: 48
Role of Steroid Hormones in the Pathogenesis of Nonalcoholic Fatty Liver Disease
Meng Yang, Feng Ma, Min Guan
Metabolites (2021) Vol. 11, Iss. 5, pp. 320-320
Open Access | Times Cited: 43
Intermittent fasting—the future treatment in NASH patients?
Iulia Minciună, Suchira Gallage, Mathias Heikenwälder, et al.
Hepatology (2023) Vol. 78, Iss. 4, pp. 1290-1305
Closed Access | Times Cited: 17
Depression and hepatobiliary diseases: a bidirectional Mendelian randomization study
Yu Kong, Zhongcai Yao, Lingli Ren, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 5
Advances in Oral Biomacromolecule Therapies for Metabolic Diseases
Qiuxia Jiao, Yuan Huang, Jinhan He, et al.
Pharmaceutics (2025) Vol. 17, Iss. 2, pp. 238-238
Open Access
The Role of Short-Chain Fatty Acids in Metabolic Dysfunction-Associated Steatotic Liver Disease and Other Metabolic Diseases
Eliane Münte, Phillipp Hartmann
Biomolecules (2025) Vol. 15, Iss. 4, pp. 469-469
Open Access
Transcriptional Regulation in Non-Alcoholic Fatty Liver Disease
Sandra Steensels, Jixuan Qiao, Baran A. Ersoy
Metabolites (2020) Vol. 10, Iss. 7, pp. 283-283
Open Access | Times Cited: 38
Role of NLRP3 inflammasome in liver disease
Abdullah Al Mamun, Afroza Akter, Sukria Hossain, et al.
Journal of Digestive Diseases (2020) Vol. 21, Iss. 8, pp. 430-436
Open Access | Times Cited: 36
The Effect of Menopausal Status, Insulin Resistance and Body Mass Index on the Prevalence of Non-Alcoholic Fatty Liver Disease
Anastasia Ntikoudi, Alketa Spyrou, Eleni Evangelou, et al.
Healthcare (2024) Vol. 12, Iss. 11, pp. 1081-1081
Open Access | Times Cited: 3
Growth differentiation factor 15: Emerging role in liver diseases
Yu Li, Jie Zhang, Shurong Chen, et al.
Cytokine (2024) Vol. 182, pp. 156727-156727
Closed Access | Times Cited: 3
Long-term intake of 9-PAHPA or 9-OAHPA modulates favorably the basal metabolism and exerts an insulin sensitizing effect in obesogenic diet-fed mice
Melha Benlebna, Laurence Balas, Béatrice Bonafos, et al.
European Journal of Nutrition (2020) Vol. 60, Iss. 4, pp. 2013-2027
Closed Access | Times Cited: 30
Regulation of gene transcription by thyroid hormone receptor β agonists in clinical development for the treatment of non-alcoholic steatohepatitis (NASH)
Xuan G. Luong, Sarah Stevens, Andreas Jekle, et al.
PLoS ONE (2020) Vol. 15, Iss. 12, pp. e0240338-e0240338
Open Access | Times Cited: 29
Insights into the Impact of Microbiota in the Treatment of NAFLD/NASH and Its Potential as a Biomarker for Prognosis and Diagnosis
Julio Plaza‐Díaz, Patricio Solis‐Urra, Jerónimo Aragón‐Vela, et al.
Biomedicines (2021) Vol. 9, Iss. 2, pp. 145-145
Open Access | Times Cited: 23
Customized liver organoids as an advanced in vitro modeling and drug discovery platform for non-alcoholic fatty liver diseases
Dong‐Wook Han, KangHe Xu, Zhe‐Long Jin, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 11, pp. 3595-3613
Open Access | Times Cited: 10
Bioinformatics analysis to reveal the potential comorbidity mechanism in psoriasis and nonalcoholic steatohepatitis
Ningyi Xian, Ruimin Bai, Jiaqi Guo, et al.
Skin Research and Technology (2023) Vol. 29, Iss. 9
Open Access | Times Cited: 9
Predicting Nonalcoholic Fatty Liver Disease through a Panel of Plasma Biomarkers and MicroRNAs in Female West Virginia Population
Sneha S. Pillai, Hari Vishal Lakhani, Mishghan Zehra, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 18, pp. 6698-6698
Open Access | Times Cited: 26
Acupuncture improved lipid metabolism by regulating intestinal absorption in mice
Jia Han, Xin Guo, Xiangjin Meng, et al.
World Journal of Gastroenterology (2020) Vol. 26, Iss. 34, pp. 5118-5129
Open Access | Times Cited: 25
Spatial expression of glucagon-like peptide 1 receptor and caveolin-1 in hepatocytes with macrovesicular steatosis in non-alcoholic steatohepatitis
Hiroaki Yokomori, Wataru Ando
BMJ Open Gastroenterology (2020) Vol. 7, Iss. 1, pp. e000370-e000370
Open Access | Times Cited: 24
Page 1 - Next Page

Scroll to top